These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9250469)

  • 1. Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
    Yoshioka K; Yokoo S; Yoshida T; Kondo M
    Diabetes Care; 1997 Aug; 20(8):1340-1. PubMed ID: 9250469
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.
    Buchanan TA; Xiang AH; Peters RK; Kjos SL; Berkowitz K; Marroquin A; Goico J; Ochoa C; Azen SP
    Diabetes; 2000 May; 49(5):782-8. PubMed ID: 10905487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
    Nolan JJ; Ludvik B; Beerdsen P; Joyce M; Olefsky J
    N Engl J Med; 1994 Nov; 331(18):1188-93. PubMed ID: 7935656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of troglitazone in treating the insulin resistance syndrome.
    Granberry MC; Schneider EF; Fonseca VA
    Pharmacotherapy; 1998; 18(5):973-87. PubMed ID: 9758309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
    Antonucci T; Whitcomb R; McLain R; Lockwood D; Norris RM
    Diabetes Care; 1997 Feb; 20(2):188-93. PubMed ID: 9118772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 11. Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome.
    Yamakita T; Ishii T; Mori T; Yoshioka K; Sato T; Tanaka S; Kurimasa H; Fujita K; Fujii S
    Diabetes Res Clin Pract; 1998 Dec; 42(3):205-8. PubMed ID: 9925352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone in progesterone derivative-induced impairment of glucose tolerance.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 2000 Apr; 39(4):348-9. PubMed ID: 10801159
    [No Abstract]   [Full Text] [Related]  

  • 15. Learning to use troglitazone.
    Riddle MC
    Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of troglitazone in type 2 diabetes mellitus.
    Gorson DM
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
    [No Abstract]   [Full Text] [Related]  

  • 17. The rise and fall of troglitazone.
    Bailey CJ
    Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of troglitazone in type 2 diabetes mellitus.
    Rusk MH
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656
    [No Abstract]   [Full Text] [Related]  

  • 19. Troglitazone: a new antihyperglycemic agent.
    Vidt DG; Speerhas RA; Reddy SS
    Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone: monotherapy indication.
    Lisi DM
    Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.